90 related articles for article (PubMed ID: 8580384)
1. Induction of circulating interleukin 10 by interleukin 1 and interleukin 2, but not interleukin 6 immunotherapy.
Tilg H; Atkins MB; Dinarello CA; Mier JW
Cytokine; 1995 Oct; 7(7):734-9. PubMed ID: 8580384
[TBL] [Abstract][Full Text] [Related]
2. Induction of circulating and erythrocyte-bound IL-8 by IL-2 immunotherapy and suppression of its in vitro production by IL-1 receptor antagonist and soluble tumor necrosis factor receptor (p75) chimera.
Tilg H; Shapiro L; Atkins MB; Dinarello CA; Mier JW
J Immunol; 1993 Sep; 151(6):3299-307. PubMed ID: 8397255
[TBL] [Abstract][Full Text] [Related]
3. Flavopiridol-related proinflammatory syndrome is associated with induction of interleukin-6.
Messmann RA; Ullmann CD; Lahusen T; Kalehua A; Wasfy J; Melillo G; Ding I; Headlee D; Figg WD; Sausville EA; Senderowicz AM
Clin Cancer Res; 2003 Feb; 9(2):562-70. PubMed ID: 12576419
[TBL] [Abstract][Full Text] [Related]
4. Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2.
Locker GJ; Kofler J; Stoiser B; Wilfing A; Wenzel C; Wögerbauer M; Steger GG; Zielinski CC; Mader R; Burgmann H
Eur Cytokine Netw; 2000 Sep; 11(3):391-6. PubMed ID: 11022123
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
[TBL] [Abstract][Full Text] [Related]
6. Induction of interleukin 1 receptor antagonist after interleukin 1 therapy in patients with cancer.
Kopp WC; Urba WJ; Rager HC; Alvord WG; Oppenheim JJ; Smith JW; Longo DL
Clin Cancer Res; 1996 Mar; 2(3):501-6. PubMed ID: 9816196
[TBL] [Abstract][Full Text] [Related]
7. Cytokine induction of interleukin-24 in human peripheral blood mononuclear cells.
Poindexter NJ; Walch ET; Chada S; Grimm EA
J Leukoc Biol; 2005 Sep; 78(3):745-52. PubMed ID: 16000394
[TBL] [Abstract][Full Text] [Related]
8. IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans.
Jablons DM; Mulé JJ; McIntosh JK; Sehgal PB; May LT; Huang CM; Rosenberg SA; Lotze MT
J Immunol; 1989 Mar; 142(5):1542-7. PubMed ID: 2783945
[TBL] [Abstract][Full Text] [Related]
9. Immunological status of patients subjected to cardiac surgery: serum levels of interleukin 6 and tumor necrosis factor alpha and the ability of peripheral blood mononuclear cells to proliferate and produce these cytokines in vitro.
Właszczyk A; Adamik B; Durek G; Kübler A; Zimecki M
Arch Immunol Ther Exp (Warsz); 1996; 44(4):225-34. PubMed ID: 9017162
[TBL] [Abstract][Full Text] [Related]
10. Elevated circulating levels of soluble interleukin-1 receptor type II during interleukin-2 immunotherapy.
Vannier E; Kaser A; Atkins MB; Fantuzzi G; Dinarello CA; Mier JW; Tilg H
Eur Cytokine Netw; 1999 Mar; 10(1):37-42. PubMed ID: 10210771
[TBL] [Abstract][Full Text] [Related]
11. The effects of aprotinin and steroids on generation of cytokines during coronary artery surgery.
Türköz A; Ciğli A; But K; Sezgin N; Türköz R; Gülcan O; Ersoy MO
J Cardiothorac Vasc Anesth; 2001 Oct; 15(5):603-10. PubMed ID: 11688002
[TBL] [Abstract][Full Text] [Related]
12. Effects of gold on cytokine production in vitro; increase of monocyte dependent interleukin 10 production and decrease of interferon-gamma levels.
Lampa J; Klareskog L; Rönnelid J
J Rheumatol; 2002 Jan; 29(1):21-8. PubMed ID: 11824965
[TBL] [Abstract][Full Text] [Related]
13. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment.
Seitz M; Zwicker M; Wider B
J Rheumatol; 2001 Mar; 28(3):496-501. PubMed ID: 11296948
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive drugs clonidine, diazoxide, hydralazine and furosemide regulate the production of cytokines by placentas and peripheral blood mononuclear cells in normal pregnancy.
Xu B; Makris A; Thornton C; Ogle R; Horvath JS; Hennessy A
J Hypertens; 2006 May; 24(5):915-22. PubMed ID: 16612254
[TBL] [Abstract][Full Text] [Related]
15. [Effects of glutamine on the cytokine expression of peripheral blood mononuclear cells].
Yang C; Wang XY; Li WQ; Li N; Li JS
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(7):449-52. PubMed ID: 18642783
[TBL] [Abstract][Full Text] [Related]
16. IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial.
Burns LJ; Weisdorf DJ; DeFor TE; Vesole DH; Repka TL; Blazar BR; Burger SR; Panoskaltsis-Mortari A; Keever-Taylor CA; Zhang MJ; Miller JS
Bone Marrow Transplant; 2003 Jul; 32(2):177-86. PubMed ID: 12838283
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of IL-12 and the production of IFN-gamma, IL-2 and IL-4 by peripheral blood mononuclear cells (PBMC) in cancer patients treated with Viscum album extract.
Kovacs E
Biomed Pharmacother; 2000 Jul; 54(6):305-10. PubMed ID: 10989963
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy.
Mantovani G; Maccio A; Madeddu C; Massa E; Mudu MC; Mulas C; Gramignano G; Massidda S; Murgia V; Lusso MR; Mura L
Int J Oncol; 2001 Feb; 18(2):383-91. PubMed ID: 11172608
[TBL] [Abstract][Full Text] [Related]
19. Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2.
Eastman ME; Khorsand M; Maki DG; Williams EC; Kim K; Sondel PM; Schiller JH; Albertini MR
Cancer; 2001 Feb; 91(4):806-14. PubMed ID: 11241250
[TBL] [Abstract][Full Text] [Related]
20. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans.
Steensberg A; Fischer CP; Keller C; Møller K; Pedersen BK
Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E433-7. PubMed ID: 12857678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
